About Turku Vaccine Research Clinic
"Rokotetutkimuskeskus on Tampereen yliopiston lääketieteen ja terveysteknologian tiedekunnan alaisuudessa toimiva erikoisyksikkö. Toteutamme tieteellisesti ja eettisesti korkeatasoisia, kliinisiä rokotetutkimuksia yhdessä rokotevalmistajien kanssa, sekä omia akateemisia tutkimushankkeita. Tavoitteemme on saada käyttöön uusia, entistä turvallisempia ja tehokkaampia rokotteita lapsille, nuorille ja aikuisille. Rokotetutkimuskeskusta johtaa professori Mika Rämet."
Clinical Trials at Turku Vaccine Research Clinic
During the past decade, Turku Vaccine Research Clinic conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 15 clinical trials were completed, i.e. on
average, 107.1% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 9 clinical trials were completed. i.e. 128.6%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Turku Vaccine Research Clinic" #1 sponsor was "Pfizer" with 14 trials, followed by "Janssen Vaccines & Prevention B.V." with 2 trials
sponsored, "Merck Sharp & Dohme LLC" with 2 trials sponsored, "Novartis Vaccines" with 1 trials sponsored and "Takeda"
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
Clinical Trials Conditions at Turku Vaccine Research Clinic
According to Clinical.Site data, the most researched conditions in "Turku Vaccine Research Clinic" are
"Meningococcal Vaccine" (4 trials), "Infections, Meningococcal" (2 trials), "Pneumococcal Infections" (2 trials), "Clostridium Difficile Infection" (1 trials) and "Hepatitis B Vaccines" (1 trials). Many other conditions were trialed in "Turku Vaccine Research Clinic" in a lesser frequency.
Clinical Trials Intervention Types at Turku Vaccine Research Clinic
Most popular intervention types in "Turku Vaccine Research Clinic" are "Biological" (19 trials), "Drug" (2 trials), "Procedure" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "Nimenrix" (2 trials), "RSVpreF" (2 trials), "Saline" (2 trials) and "rLP2086" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Turku Vaccine Research Clinic
The vast majority of trials in "Turku Vaccine Research Clinic" are
20 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Turku Vaccine Research Clinic
Currently, there are NaN active trials in "Turku Vaccine Research Clinic".
undefined are not yet recruiting,
1 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 18 completed trials in Turku Vaccine Research Clinic,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Turku Vaccine Research Clinic, 1 "Phase 1"
clinical trials were conducted, 7 "Phase 2" clinical
trials and 14 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".